Target intelligence / Profile preview

Alpha-crystallin B chain (CRYAB)

Target
CRYAB
Molecular classification
Small heat shock protein, Molecular chaperone, Structural protein, Other (Alpha-crystallin protein family)
01

Overview

Alpha-crystallin B chain is a small heat shock protein encoded by the CRYAB gene in humans. It serves as a molecular chaperone that binds misfolded proteins to prevent their aggregation, protects cells from stress-induced apoptosis, and maintains the architecture of muscle and lens cells. This protein is abundant in the eye lens, where its stability is crucial for lens transparency, but it also exists in many tissues including muscle, heart, and brain. Mutations in CRYAB are associated with inherited cardiac and skeletal muscle myopathies, cataract, cancers, and neurodegenerative diseases. Alpha-crystallin B chain operates as part of large, heterogeneous complexes, and its activity can be modulated by post-translational modifications[1][3][5][8].

Other names
HspB5Heat shock protein beta-5αB-crystallinAlpha-B crystallin
02

Mechanism of action

Not a direct drug target; however, in preclinical models, modulation of chaperone function or expression can alter protein aggregation in disease contexts

03

Biological functions

Prevention of protein aggregationMolecular chaperone activityInhibition of apoptosis (cell death)Maintenance of cytoskeletal integrityStructural maintenance of lens transparency
04

Disease associations

CataractCardiomyopathyMyofibrillar myopathyCancerNeurodegenerative disease (e.g., Alzheimer's, Parkinson's)
05

Safety considerations

Not directly targeted therapeutically, but its loss or mutation causes genetic disease (e.g., myopathy, cataract)Potential concerns with off-target effects if used in therapy to modulate chaperone activity
06

Biomarkers

Used as a biomarker for some myopathies, cardiomyopathies, and certain cancers

Beyond the preview

Go deeper on Alpha-crystallin B chain (CRYAB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-crystallin B chain (CRYAB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call